Mariateresa Allocca
Overview
Explore the profile of Mariateresa Allocca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sannino A, Allocca M, Scarfi M, Romeo S, Zeni O
Bioelectromagnetics
. 2024 Sep;
45(8):365-374.
PMID: 39315584
In our previous studies, we demonstrated that 20 h pre-exposure of SH-SY5Y human neuroblastoma cells to 1950 MHz, UMTS signal, at specific absorption rate of 0.3 and 1.25 W/kg, was...
2.
Sannino A, Romeo S, Scarfi M, Pinchera D, Schettino F, Alonzo M, et al.
Bioelectromagnetics
. 2023 Jul;
45(3):97-109.
PMID: 37493434
This study aims to investigate the cellular effects of radiofrequency exposure, 1950 MHz, long-term evolution (LTE) signal, administered alone and in combination with mitomycin-C (MMC), a well-known cytotoxic agent. Chinese...
3.
Monticelli M, Mele B, Allocca M, Liguori L, Lukas J, Monti M, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36674610
Fabry disease is a lysosomal storage disease caused by mutations in the gene that encodes alpha-galactosidase (AGAL). The disease causes abnormal globotriaosylceramide (Gb3) storage in the lysosomes. Variants responsible for...
4.
Falcao M, Allocca M, Rodrigues A, Granjo P, Francisco R, Pascoal C, et al.
Int J Environ Res Public Health
. 2023 Jan;
20(2).
PMID: 36673723
At least 50% of chronic disease patients don't follow their care plans, leading to lower health outcomes and higher medical costs. Providing Patient Education Materials (PEMs) to individuals living with...
5.
Vignogna R, Allocca M, Monticelli M, Norris J, Steet R, Perlstein E, et al.
Elife
. 2022 Oct;
11.
PMID: 36214454
The most common cause of human congenital disorders of glycosylation (CDG) are mutations in the phosphomannomutase gene which affect protein -linked glycosylation. The yeast gene encodes a homolog of human...
6.
Brasil S, Allocca M, Magrinho S, Santos I, Raposo M, Francisco R, et al.
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955863
Advances in research have boosted therapy development for congenital disorders of glycosylation (CDG), a group of rare genetic disorders affecting protein and lipid glycosylation and glycosylphosphatidylinositol anchor biosynthesis. The (re)use...
7.
Monticelli M, Liguori L, Allocca M, Bosso A, Andreotti G, Lukas J, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563496
Fabry disease is caused by a deficiency of lysosomal alpha galactosidase and has a very large genotypic and phenotypic spectrum. Some patients who carry hypomorphic mutations can benefit from oral...
8.
Liguori L, Monticelli M, Allocca M, Cubellis M, Mele B
BMC Bioinformatics
. 2020 Aug;
21(Suppl 10):348.
PMID: 32838733
Background: Bioinformatics has pervaded all fields of biology and has become an indispensable tool for almost all research projects. Although teaching bioinformatics has been incorporated in all traditional life science...
9.
Dessi A, Peluso P, Dallocchio R, Weiss R, Andreotti G, Allocca M, et al.
Molecules
. 2020 May;
25(9).
PMID: 32397334
The 3,3',5,5'-tetrachloro-2-iodo-4,4'-bipyridine structure is proposed as a novel chemical scaffold for the design of new transthyretin (TTR) fibrillogenesis inhibitors. In the frame of a proof-of-principle exploration, four chiral 3,3',5,5'-tetrachloro-2-iodo-2'-substituted-4,4'- bipyridines...
10.
Liguori L, Monticelli M, Allocca M, Mele B, Lukas J, Cubellis M, et al.
Int J Mol Sci
. 2020 Jan;
21(2).
PMID: 31940970
The term "pharmacological chaperone" was introduced 20 years ago. Since then the approach with this type of drug has been proposed for several diseases, lysosomal storage disorders representing the most...